BioDrugs
Издатель: Springer Nature · ISSN 1173-8804,1179-190X · 121 статей
- Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen–Directed CAR T-Cell Therapy
- Recombinant Protein Drugs: A 2025 Update
- Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders
- Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
-
Recent Developments in Lipid Nanoparticle-Mediated Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier
Abstract Peripherally administered therapeutics for neurological indications are challenged with anatomical and physiological barriers that limit their ability to access their site of action in the central nervous system (CNS). This is...
- Site-Specific Genomic Markers Associated with Outcomes of PD-1 Blockade in Gastric and Esophagogastric Junction Cancer: Analysis of Japan’s C-CAT Registry
- Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with Diabetes
- Interleukin-23 Inhibitors in Inflammatory Bowel Disease
- Progress in Designing Cytokine Antagonist Antibodies for Cancer Therapy
- Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
- Clinical Benefit and Global Regulation of Bispecific Antibody Drugs: A Cross-sectional Analysis
- The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities
- In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation
- Effectiveness of Lebrikizumab Treatment for Patients with Atopic Dermatitis Switched from Dupilumab or Tralokinumab: A 48-Week Real-World Retrospective Study
- Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?
- Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics
- Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
- Advances in Engineered Virus-Like Particles for Genome Editing and Therapy
- Navigating the Transition: A Scoping Review of System-Level Factors in Biosimilar Integration for Immune-Mediated Inflammatory Diseases
- Antibody-Drug Conjugates in Gynecologic Oncology: Advances, Challenges, and Future Directions
- Web of Potentials: Neuroactive Components of Spider Venom and Their Emerging Pharmacologic Applications in Neurologic Diseases
- Phase I Studies of HLX26, A Novel Anti-LAG-3 Antibody, Monotherapy or Combination Therapy in Patients with Advanced Solid Tumors
- The Role of OX40 Pathway Inhibition as a New Therapeutic Strategy for Atopic Dermatitis
- Immunogenicity of Gene and Cell Therapies
- Antisense Oligonucleotide Therapeutics Targeting Age-Related Diseases
- Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential
- Harnessing Nanocarriers to Advance Vaccine Development
- Recombinant Molecules as a New Frontier in Mucositis Therapy
- Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
- Biosimilar Uptake in Spain from 2016 to 2023: Analysis Based on Official Data Collection